Oncoclínicas do Brasil Serviços Médicos S.A.

BOVESPA:ONCO3 Voorraadrapport

Marktkapitalisatie: R$2.8b

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Oncoclínicas do Brasil Serviços Médicos Beheer

Beheer criteriumcontroles 1/4

De CEO Oncoclínicas do Brasil Serviços Médicos' is Bruno Ferrari, benoemd in Jan2010, heeft een ambtstermijn van 14.75 jaar. bezit rechtstreeks 8.65% van de aandelen van het bedrijf, ter waarde R$ 245.74M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 2.5 jaar en 0.8 jaar.

Belangrijke informatie

Bruno Ferrari

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEO14.8yrs
Eigendom CEO8.7%
Management gemiddelde ambtstermijn2.5yrs
Gemiddelde ambtstermijn bestuurless than a year

Recente managementupdates

Recent updates

With A 25% Price Drop For Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3) You'll Still Get What You Pay For

Sep 27
With A 25% Price Drop For Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3) You'll Still Get What You Pay For

Here's What Analysts Are Forecasting For Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3) After Its Second-Quarter Results

Aug 15
Here's What Analysts Are Forecasting For Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3) After Its Second-Quarter Results

Oncoclínicas do Brasil Serviços Médicos (BVMF:ONCO3) Takes On Some Risk With Its Use Of Debt

Aug 13
Oncoclínicas do Brasil Serviços Médicos (BVMF:ONCO3) Takes On Some Risk With Its Use Of Debt

Earnings Tell The Story For Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3) As Its Stock Soars 27%

Jul 16
Earnings Tell The Story For Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3) As Its Stock Soars 27%

Is Now An Opportune Moment To Examine Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3)?

Jul 03
Is Now An Opportune Moment To Examine Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3)?

Investors Appear Satisfied With Oncoclínicas do Brasil Serviços Médicos S.A.'s (BVMF:ONCO3) Prospects As Shares Rocket 25%

Jun 01
Investors Appear Satisfied With Oncoclínicas do Brasil Serviços Médicos S.A.'s (BVMF:ONCO3) Prospects As Shares Rocket 25%

Oncoclínicas do Brasil Serviços Médicos S.A.'s (BVMF:ONCO3) Share Price Is Still Matching Investor Opinion Despite 27% Slump

Apr 17
Oncoclínicas do Brasil Serviços Médicos S.A.'s (BVMF:ONCO3) Share Price Is Still Matching Investor Opinion Despite 27% Slump

Oncoclínicas do Brasil Serviços Médicos' (BVMF:ONCO3) Earnings Are Weaker Than They Seem

Apr 03
Oncoclínicas do Brasil Serviços Médicos' (BVMF:ONCO3) Earnings Are Weaker Than They Seem

Oncoclínicas do Brasil Serviços Médicos (BVMF:ONCO3) Has A Somewhat Strained Balance Sheet

Mar 11
Oncoclínicas do Brasil Serviços Médicos (BVMF:ONCO3) Has A Somewhat Strained Balance Sheet

What Does Oncoclínicas do Brasil Serviços Médicos S.A.'s (BVMF:ONCO3) Share Price Indicate?

Feb 17
What Does Oncoclínicas do Brasil Serviços Médicos S.A.'s (BVMF:ONCO3) Share Price Indicate?

It's A Story Of Risk Vs Reward With Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3)

Dec 08
It's A Story Of Risk Vs Reward With Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3)

Why Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3) Could Be Worth Watching

Nov 06
Why Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3) Could Be Worth Watching

Is Now The Time To Put Oncoclínicas do Brasil Serviços Médicos (BVMF:ONCO3) On Your Watchlist?

Sep 11
Is Now The Time To Put Oncoclínicas do Brasil Serviços Médicos (BVMF:ONCO3) On Your Watchlist?

Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3) Just Reported Earnings, And Analysts Cut Their Target Price

Apr 03
Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3) Just Reported Earnings, And Analysts Cut Their Target Price

CEO

Bruno Ferrari

14.8yrs

Tenure

Mr. Bruno Lemos Ferrari is CEO and Director of Oncoclínicas do Brasil Serviços Médicos S.A. from 2010 and serves as its Vice Chairman since May 2022. Mr. Ferrari is full member of the Brazilian Society of...


Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Bruno Ferrari
Vice Chairman & CEO14.8yrsgeen gegevens8.65%
R$ 245.7m
Cristiano Affonso de Camargo
Chief Financial and Investor Relations Officer2.5yrsgeen gegevensgeen gegevens
Raoni Larena
Director of M&A and Operationsless than a yeargeen gegevensgeen gegevens
Ricardo da Santoro
Chief Technology Officer2.8yrsgeen gegevensgeen gegevens
Cinthia Ambrogi
Director of Compliance & Legalno datageen gegevensgeen gegevens
Guilherme Ferri
Marketing Officerno datageen gegevensgeen gegevens
Giovane Reus da Costa
Human Resources Officerno datageen gegevensgeen gegevens
Joao Figueiredo Padin
Chief Strategy Officer & Board Memberless than a yeargeen gegevensgeen gegevens

2.5yrs

Gemiddelde duur

Ervaren management: Het managementteam van ONCO3 wordt beschouwd als ervaren (gemiddelde ambtstermijn 2.5 jaar).


Bestuursleden

NaamPositieTenureCompensatieEigendom
Bruno Ferrari
Vice Chairman & CEO14.8yrsgeen gegevens8.65%
R$ 245.7m
Cristiano Affonso de Camargo
Chief Financial and Investor Relations Officerless than a yeargeen gegevensgeen gegevens
Joao Figueiredo Padin
Chief Strategy Officer & Board Memberno datageen gegevensgeen gegevens
Reginaldo Alexandre
Member of Fiscal Councilless than a yeargeen gegevensgeen gegevens
David Castelblanco
Chairmanno datageen gegevensgeen gegevens
Eric Winer
Director2.4yrsgeen gegevensgeen gegevens
Marcus Vinicius Severini
President of the Fiscal Council1.8yrsgeen gegevensgeen gegevens
Flavia Bittencourt
Board Memberno datageen gegevensgeen gegevens
Jeffrey Bernstein
Board Memberless than a yeargeen gegevensgeen gegevens
Allen Mc Gibson
Board Memberno datageen gegevensgeen gegevens
Clarissa de Cerqueira Mathias
Board Memberno datageen gegevensgeen gegevens
Marcelo del Vigna
Independent Directorless than a yeargeen gegevensgeen gegevens

0.8yrs

Gemiddelde duur

59.5yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van ONCO3 wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 0.8 jaar), wat duidt op een nieuw bestuur.